Анестезия и педиатрия - Джордж А.Г.
ISBN 5-225-03821-2
Скачать (прямая ссылка):
200. Martyn JA, Goudsouzian NG, Chang Y, et al: Neuromuscular effects of mivacurium in 2- to 12-yr-okl children with bum ityury. Anesthesiology 92:31, 2000
201. Markakis DA, Hart PS, Lau M, et al: Does age or pseu-docholinesterase activity predict mivacurium infusion rate in children? Anesth Analg 82:39, 1996
202. Green DW, Fisher M, Sockalingham I: Mivacurium compared with succinylcholine in children with liver disease. BrJ Anaesth 81:463, 1998
203. McCourt КС, Salmela L, Mirakhur RK, et al: Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 53:867, 1998
204. Mazurek AJ, Rae B, Hann S, et al: Rocuronium versus succinylcholine: are they equally effective during rapkl-sequence induction of anesthesia? Anesth Analg 87:1259, 1998
205. Woolf RL. Crawford MW. Choo SM: Dose-response of
Фармаколога я 63
rociiFonium bromide in children anesthetized with propo-fol: a comparison with succinycholine. Anesthesiology 87:) 368, 1997
206. Reynolds LM. Liu M, Brown R, et al: Bioavailabjlty of intramuscular rocuronium in infants and children. Anesthesiology 87:10%, 1997
207. Wiewfci JM. Meretoja OA, Taivainen T, Proosi JH: Pharmacokinetics and pharmacokinetic-dynamic modeling of rociifonitim in infants and children. Br J Anacsth 78:690,
1997
208. Vuksanaj D, Fisher DM: Pharmacokinetics of rocuronium in children aged 4—11 years. Anesthesiology 82:1104, 1995
209. O’Kelly B, Fiset P, Meistelman C, Ecoffey C: Pharma-cokinctics of rocuronium bromide in paediatric patients. Eur J Anaesthesiol Suppl 9:57, (994
210. Khuenl-Brady KS, Sparr H: Clinical pharmacokinetics of rocuroninm bromide. Clin Pharmacol 31:174, 19%
211. Mcretoju OA, Taivainen T, Erkola O, et al: Dose-response and і і me-course of effect of rocuronium bromide in paediatric patients. Eur J Anaesthesiol Suppl 11:19, 1995
212. Wierda JM, Schuritiga M, van den Broek L: Cardiovascular effects of an intubating dose of rocuronium 0.6 mg kg-1 in anaesthetized patients, paralysed with vecuronium. Br J Anacsth 78:586, 1997
213. Abdolatif M, Mowafi H, al-Gbamdi A, el-Sanabary M: Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. Br J Anaesth 77:710, 19%
214. Mcakin GH, Mcreioja OA, Moisch J, et a|: A dose-ranging study of rapacuronium in pediatric patients. Anesthesiology 92:1002. 2000
215. Brandon BW, Maigolis JO, BikhaziGB.et al: Neuromus-cular effects of rapacuronium in padiatric patients during nitrous oxidehalothane anesthesia: comparison with miva-curonium. Can J Anaesth 47:143, 2000
216. Reynolds LM, Infosino A, Brown R, et al: Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration. Anesthesiology 92:376, 2000
217. Mills KG, Wright PM, Pollard BJ, et al: Antagonism of rapacuronium usir® edrophonium or neostigmine: pharmacodynamics and pharmacokinetics. Br J Anacsth 83:727, 1999
218. Fisher DM, Cronnelly R, Miller RD, Stuirma M: The neuromuscular pharmacology of neostigmine in infants and children. Anesthesiology 59:220. 1983
219. Fisher DM, Cronnelly R, Sharma M, Miller RD: Clinical pharmacology of edrophonium in infants and children. Anesthesiology 61:428, 1984
220. Rackow H, Salanitre E: Modem concepts in pediatric anesthesiology. Anesthesiology 30:208, 1969
22). Liu LMP. Cote CJ, Goudsouzian NG et al: Life-threatening apnea in infants recovering from anesthesia. Anesthesiology 59:586, 1983
222. Cook DR, Fisher BH: Neuromuscular blocking effects of succinylcholinc in inflints and children. Anesthesiolocy 42:662, 1975
223. Goudsouzian NG, Liu LMP: The neuromuscular response of infants to continuous infusion of succinylcholinc. Anesthesiology 60:97. 1984
224. Escobichon DJ, Stephens DS: Perinatal development of human esterases. Clin Pharmacol Ther 14:41, 1973
225. Mirakhur RK, Elliott P. Lavery TD: Plasma cholincste-rase activity and the duration of suxamethonium apnoae in children. Ann R Coll Sing 66:43, 1984
226. Strauss AA. Modanlou HD: Transient plasma cholinestc-rase deficiency in preterm infants. Dev Pharamcol Ther 9:82, 1986
227. Katow W, Benst K: A method for the detection of atypical forms of human serum cholinestcrase; determination of dibucaine numbers. Can J Biochem Phys 35:339, 1957
228. Pantuck EJ, Panttick CB: Cholincsterases and anticholinesterases. p. 143. In Katz RL (ed): Muscle Relaxant*. Excerpta Medica, Amsterdam. 1975. p. 143
229. Viby-Moge risen J: Correlation of succinylcholinc duration of action with plasma cholinestcrase activity in subjects with a genotypically normal enzyme. Anesthesiology 53:517, 1980
230. Viby-Moge nsen J: Succinyocholine neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Anesthesiology 55:231, 1981
231. Cook R, Fischer CG: Characteristics of succinylcholinc in infants and children. Anesthesiology 42*62, 1975
232. DeCook TH, Goudsouzian NG: Tachyphylaxis and phase (I block development during infusion of succinylcholine in children. Anesth Analg 59:639, 1980
